Aortic stenosis
RecruitingStudy of beta blockers in patients with aortic stenosis undergoing transcatheter aortic valve replacement
- Disease:Aortic stenosis
- Substances:–
Austria- Participants:18–64 years · 65+ years
- Sponsor:Universitaetsspital Basel
Rare diseases
Investigational molecules
Locations
Petersgraben 4, 4031
Clinical research includes aortic stenosis and peri-procedural management in patients undergoing TAVR, with interest in cardiovascular optimisation around valve intervention.
The sponsor is also involved in studies examining medication use in the setting of structural heart disease and valve replacement care.
Universitaetsspital Basel runs clinical trials in conditions such as Osteoarthritis, Aortic stenosis, Diabetes insipidus, Atrial fibrillation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
Austria
Germany
Croatia
Germany
Greece
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.